Condensed Statements of Changes in Stockholders' Deficit - USD ($) $ in Thousands	Total	Public Equity Offering - ATM	Public Equity Offering	Common Stock	Common Stock Public Equity Offering - ATM	Additional Paid-in Capital	Additional Paid-in Capital Public Equity Offering - ATM	Additional Paid-in Capital Public Equity Offering	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023				68,533,085
Beginning balance at Dec. 31, 2023	$ (106,487)			$ 69		$ 212,521			$ (319,077)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock issued under public equity offering (in shares)				16,666,667	4,557,220
Common Stock issued under public equity offering	75,000	$ 12,385		$ 17	$ 4	74,983	$ 12,381
Costs of common stock issued under public equity offering		(410)					(410)
Costs of common stock issued under public equity offering			$ (5,187)					$ (5,187)
Share-based compensation expense	1,580					1,580
Vested restricted stock units, net (in shares)				490,359
Vested restricted stock units, net	(893)					(893)
Options exercises, net (in shares)				231,400
Options exercised, net	539					539
Net loss	(12,828)								(12,828)
Ending balance (in shares) at Mar. 31, 2024				90,478,731
Ending balance at Mar. 31, 2024	(36,301)			$ 90		295,514			(331,905)
Beginning balance (in shares) at Dec. 31, 2024				91,413,742
Beginning balance at Dec. 31, 2024	(60,156)			$ 91		302,967			(363,214)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock issued under public equity offering (in shares)					7,457,627
Common Stock issued under public equity offering		22,000			$ 8		21,992
Costs of common stock issued under public equity offering		$ (729)					$ (729)
Share-based compensation expense	1,587					1,587
Vested restricted stock units, net (in shares)				445,784
Vested restricted stock units, net	(702)					(702)
Net loss	(22,930)								(22,930)
Ending balance (in shares) at Mar. 31, 2025				99,317,153
Ending balance at Mar. 31, 2025	$ (60,930)			$ 99		$ 325,115			$ (386,144)